PDS Biotechnology Corporation (PDSB) Operating income 2016–2025
PDS Biotechnology Corporation (PDSB) annual operating income history from SEC filings — each fiscal year as reported.
-$31.5MFY2025 · since FY2016: -$39.5M → -$31.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.5M | +13.2% |
| FY2024 | -$36.3M | +15.6% |
| FY2023 | -$43.0M | -3.3% |
| FY2022 | -$41.7M | -94.4% |
| FY2021 | -$21.4M | -43.9% |
| FY2020 | -$14.9M | +29.2% |
| FY2019 | -$21.0M | -476.9% |
| FY2018 | -$3.6M | +93.0% |
| FY2017 | -$52.0M | -31.5% |
| FY2016 | -$39.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PDSB financial trends
PDSB RevenuePDSB Net incomePDSB Net marginPDSB Gross profitPDSB Gross marginPDSB Operating marginPDSB Operating cash flowPDSB Free cash flowPDSB Capital expendituresPDSB Return on equityPDSB Stock buybacksPDSB Dividends paidPDSB Total assetsPDSB Total liabilitiesPDSB Shareholders’ equityPDSB overview →